Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by Momo25on Jan 06, 2023 11:08pm
139 Views
Post# 35208373

RE:RE:Therapeutic window

RE:RE:Therapeutic window''... they must have something they are holding onto for hope. That suggests some efficacy has been seen which might be repeatable with a less toxic outcome or vice versa..''.
More of the same. 
If they really have seen any efficacy they could argue the pause is to adapt their plan or something like that. In their statement they cleaarly stated that continuing that path is not worth it. All the bla bla around the reason of the pause is meaningless. They just can't say the program is a failure. Otherwise, the SP would collapse. They try the pause term instead. At one point they will declare the oncology program is stopped because......FDA did not validate their approach !!!
<< Previous
Bullboard Posts
Next >>